Covered recipient · General Payments record
JOHN CAREY
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$1,989.85
- Reported across 118 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $610.81 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $261.00 | 22 |
| REVANCE THERAPEUTICS, INC. | $153.04 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $75.17 | 3 |
| Lilly USA, LLC | $37.96 | 2 |
| Galderma Laboratories, L.P. | $32.41 | 2 |
| Amgen Inc. | $30.87 | 1 |
| Incyte Corporation | $20.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.54 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416017 | CMS |
| ABBVIE INC. | $9.48 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416019 | CMS |
| ABBVIE INC. | $6.83 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416021 | CMS |
| ABBVIE INC. | $4.46 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416023 | CMS |
| ABBVIE INC. | $27.77 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416025 | CMS |
| ABBVIE INC. | $4.82 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416027 | CMS |
| ABBVIE INC. | $32.58 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416029 | CMS |
| ABBVIE INC. | $22.64 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416031 | CMS |
| ABBVIE INC. | $7.39 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416033 | CMS |
| ABBVIE INC. | $12.87 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416035 | CMS |
| ABBVIE INC. | $25.71 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416037 | CMS |
| ABBVIE INC. | $8.12 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416039 | CMS |
| ABBVIE INC. | $6.21 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416041 | CMS |
| ABBVIE INC. | $5.70 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416043 | CMS |
| ABBVIE INC. | $8.35 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416045 | CMS |
| ABBVIE INC. | $15.94 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416047 | CMS |
| ABBVIE INC. | $7.92 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416049 | CMS |
| ABBVIE INC. | $6.60 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416051 | CMS |
| ABBVIE INC. | $6.11 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416053 | CMS |
| ABBVIE INC. | $0.45 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416055 | CMS |
| ABBVIE INC. | $7.55 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416057 | CMS |
| ABBVIE INC. | $26.96 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103416059 | CMS |
| Amgen Inc. | $30.87 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117217709 | CMS |
| Galderma Laboratories, L.P. | $17.22 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145288998 | CMS |
| Galderma Laboratories, L.P. | $15.19 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145289000 | CMS |
| Incyte Corporation | $20.36 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141289118 | CMS |
| Lilly USA, LLC | $14.13 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135070779 | CMS |
| Lilly USA, LLC | $23.83 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135031558 | CMS |
| REVANCE THERAPEUTICS, INC. | $94.10 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147913961 | CMS |
| REVANCE THERAPEUTICS, INC. | $58.94 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147913963 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $26.54 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152161849 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $26.21 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152161851 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $22.42 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152161853 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.